Home > Healthcare > Biotechnology > Bioservices > Genotyping Market

Genotyping Market Size

Report ID: GMI7567
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Genotyping Market Size

Genotyping Market size was valued at USD 18.2 billion in 2022 and is estimated to grow at a CAGR of 15.9% between 2023 and 2032. The market is experiencing robust growth, propelled by several key drivers that are shaping the landscape of genetic analysis.

To get key market trends

Download Free Sample

The advent of high-throughput genotyping platforms have significantly enhanced the speed and accuracy of genetic testing, thereby fostering increased adoption across various research and clinical applications. Also, expanding scope of precision medicine and the growing significance of genomics in disease diagnostics and treatment planning are pivotal drivers fuelling the market growth. Additionally, surging interest in understanding genetic variations and their correlation with disease susceptibility, treatment response, and overall health outcomes is another key factor propelling the market forward.

Genotyping is the process of determining the genetic makeup of an individual or organism. It involves analysing an organism's DNA to identify variations in specific genes or genetic markers. These genetic variations can include single nucleotide polymorphisms (SNPs), insertions, deletions, or other type of mutations. Further, genotyping is widely used in various fields including genetics research, medicine, and forensics.

Genotyping Market Report Attributes
Report Attribute	Details
Base Year:	2022
Genotyping Market Size in 2022:	USD 18.2 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	15.9%
2032 Value Projection:	USD 78 Billion
Historical Data for:	2018 to 2022
No. of Pages:	280
Tables, Charts & Figures:	482
Segments covered:	Products & Services, Technology, Application, End-use, & Region
Growth Drivers:	Increasing demand for personalized medicine Rising incidence of genetic disorders Technological advancements in genotyping platforms Growing investments and funding in genomic research
Pitfalls & Challenges:	High cost of genotyping technology Stringent regulatory processes

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Genotyping industry size reached USD 18.2 billion in 2022 and is set to exhibit 15.9% CAGR from 2023 to 2032 driven by the advent of high-throughput genotyping platforms to offer enhanced speed and accuracy of genetic testing.

Genotyping industry from the reagents & kits segment generated USD 8.3 billion in revenue in 2022 and is estimated to record substantial growth through 2032 due to surging demand to facilitate accurate and high-throughput genotyping processes.

North America held 41.4% revenue share of the genotyping market in 2022 and is estimated to expand at a notable CAGR attributed to the technological advancements, increasing R&D activities, and the growing demand for personalized medicine.

Some of the major genotyping firms are Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V, F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., GE Healthcare Technologies Inc., and Bio-Rad Laboratories Inc., among others.